SEC Form 4 · accession 0001628280-26-040581
NEOGENOMICS INC · NEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John P. Kenny
Director
Period of report
Jun 1, 2026
Accepted (ET)
Jun 3, 2026 · 7:48 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001077183
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2026 | M | 5,893 | $0.00 | A | 5,893 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF2 | $0.00 | Jun 1, 2026 | M | 5,893 | D | Jun 1, 2026 | — | Common Stock | 5,893 | 0 | D |
| Stock Option (Right to Buy) | $10.52 | Jun 1, 2026 | A | 11,069 | A | Jun 1, 2027 | Jun 1, 2036 | Common Stock | 11,069 | 11,069 | D |
| Restricted Stock UnitF2 | $0.00 | Jun 1, 2026 | A | 15,970 | A | Jun 1, 2027 | — | Common Stock | 15,970 | 15,970 | D |
| Stock Option (Right to Buy) | $11.76 | holding | — | — | — | Jun 1, 2026 | Jan 1, 2036 | Common Stock | 4,171 | 4,171 | D |
Explanation of responses
- F1Reflects release of restricted stock units that were previously reported on a Form 4.
- F2Once vested, the shares of common stock are not subject to expiration.